HomeAARD • NASDAQ
add
Aardvark Therapeutics Inc
Previous close
$3.54
Day range
$3.41 - $3.66
Year range
$3.41 - $17.94
Market cap
75.05M USD
Avg Volume
392.62K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.70M | 97.93% |
Net income | -17.60M | -100.46% |
Net profit margin | — | — |
Earnings per share | -0.81 | — |
EBITDA | -18.69M | -97.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 110.03M | 49.37% |
Total assets | 117.18M | 51.19% |
Total liabilities | 10.55M | 95.55% |
Total equity | 106.63M | — |
Shares outstanding | 21.78M | — |
Price to book | 0.72 | — |
Return on assets | -37.35% | — |
Return on capital | -40.66% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -17.60M | -100.46% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2017
Website
Employees
33
